21 April 2022

GSK Stockmann again recognized among the leading law firms in Luxembourg by The Legal 500 EMEA

The Legal 500 Europe, Middle East and Africa (EMEA) has published its rankings for 2022 and recognizes GSK Stockmann once again among the leading law firms in Luxembourg with practice and individual mentions based on its annual survey of the legal services market.

The following practices are ranked:

  • Banking, Finance and Capital Markets
  • Investment Funds
  • Tax

The following lawyers received mentions:

  • Banking, Finance and Capital Markets
    • Leading individual: Andreas Heinzmann
    • Other key lawyers: Valerio Scollo, Manuel Fernandez

  • Investment Funds
    • Recommended lawyer: Marcus Peter

  • Tax
    • Recommended lawyer: Mathilde Ostertag
    • Other key lawyer: Katharina Schiffmann

The full results are available at The Legal 500 EMEA.

In addition to boosting GSK Stockmann’s regional reputation, the rankings highlight the ongoing strategic growth and development of the Luxembourg office since its inception in 2016. A sincere thanks goes to all clients for their positive feedback and ongoing trust. Congratulations to our teams and lawyers highlighted in the rankings for their ongoing hard work and commitment.

The Legal 500 EMEA guide provides researched coverage of over 80 countries and over 2,700 ranked law firms. Law firms pay nothing to participate and ranking decisions are based on merit alone. The research process is conducted annually, providing a detailed qualitative assessment of various factors including work conducted by law firms over the past 12 months and historically; experience and depth of teams; specialisms and ancillary services; and, opinions of law firms’ clients.

Print


Press contact
Beate Dünschede
+352 271802-29
beate.duenschede@gsk-lux.com

Back

GSK Updates
  • 10.02.2022

    GSK Update: Update of the Luxembourg Securitisation Law: Increased Flexibility and Legal Certainty

    Read more
  • 27.01.2022

    GSK Update: CSSF Guidance on Virtual Assets: New FAQ for UCI and credit institutions

    Read more
  • 03.08.2021

    GSK Update: Cross-Border Distribution Directive implemented – What you should know

    Read more
© GSK Stockmann 2022